Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tashia
    Junior Member
    • Oct 2018
    • 4

    Ribosomal RNA contamination

    Hi everyone,

    I have a question in relation to a differential expression analysis that I ran with rRNA contaminated samples.

    Essentially, my samples had 60-70% rRNA content, but I chose to go ahead with the analysis once removing these sequences since I had enough reads to work with (15-20M). Contamination was seen in both cases and controls.

    However, what I am wondering now is if I can trust the results I am seeing? Is there any way that high rRNA content can affect patterns of expression? Comparing results with cases and controls with no contamination I see 1. More DEGs in the non-contaminated sample 2. Different DEGs (only 1 gene overlap). Of course they are different people but they do have the same disease and the controls are matched so I am a bit at a loss to whether this makes sense

    Hope this was clear.
    Many thanks.
  • tashia
    Junior Member
    • Oct 2018
    • 4

    #2
    Bumping my own post.

    Comment

    • ddb
      Member
      • Feb 2012
      • 13

      #3
      Can you give some more details about your experiment set up and the methods / pipeline you are using. Is it possible that in your contaminated samples you do not have enough coverage to identify most of the differentially expressed genes?

      Comment

      • tashia
        Junior Member
        • Oct 2018
        • 4

        #4
        Originally posted by ddb View Post
        Can you give some more details about your experiment set up and the methods / pipeline you are using. Is it possible that in your contaminated samples you do not have enough coverage to identify most of the differentially expressed genes?
        I should have enough coverage in the contaminated samples. I had approximately 75M reads before removing the rRNA sequences.

        The pipeline is removing rRNA sequences with bbduk, trimming with trimmomatic, aligning with STAR (latest HG38 version) counting with HTseq and finally DESeq2. About half of the samples were contaminated but were sequenced at a greater depth to achieve the same coverage as in the non-contaminated samples once removing the rRNA content. A PCA plot shows that the contaminated samples are clearly distinct from the "good" batch. I have controlled for batch (and tried several tools) but the PCA plot still shows a clear distinction. It feels like either this seperation is due to that these samples were sequenced at two different times (but many people work with samples like this and I think I should be able to control for this) OR due to the fact that they had a lot of rRNA during sequencing.

        Do you think that expression levels can be affected by a high content of rRNA in the sample while sequencing?

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          Do you think that expression levels can be affected by a high content of rRNA in the sample while sequencing?
          Not likely. For a sequencer it is just DNA. Does not matter if it came from rRNA or some other gene. If the two sets of runs happened on two different chemistries or different machines then may be something else to consider.

          If your samples were all treated the same how come you have rRNA contamination in some samples but not others?

          Comment

          • tashia
            Junior Member
            • Oct 2018
            • 4

            #6
            Originally posted by GenoMax View Post
            Not likely. For a sequencer it is just DNA. Does not matter if it came from rRNA or some other gene. If the two sets of runs happened on two different chemistries or different machines then may be something else to consider.

            If your samples were all treated the same how come you have rRNA contamination in some samples but not others?
            Thanks for your reply.
            Unfortunately the rRNA depletion failed in about half of the samples and instead of re-doing the libraries the sequencing facility sequenced at a greater coverage instead...

            They should have been run on the same machine and the only difference is that they were run at different times and then of course the contamination. However, if the rRNA contamination shouldn't cause any problems, I don't know why I can't control for this batch effect that I see in the PCA plot I have tried including batch in the model in DESeq2 and EdgeR. I have also tried correcting with RUVseq and ComBat. I am now looking into ImpulseDE2.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            34 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            44 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Working...